clinical trials

A Missed Alzheimer’s Opportunity? Not So Much
A Missed Alzheimer’s Opportunity? Not So Much
In the Pipeline
Pfizer
Enbrel
Alzheimer's disease
social media
clinical trials
journalism
Flag link:
Takeda suffers another setback in its quest to expand myeloma drug’s reach — and blockbuster potential
Takeda suffers another setback in its quest to expand myeloma drug’s reach — and blockbuster potential
Endpoints
Takeda
Ninlaro
clinical trials
Flag link:
AstraZeneca ends another Calquence trial early
AstraZeneca ends another Calquence trial early
Pharmaforum
AstraZeneca
CLL
Calquence
clinical trials
Flag link:
Biotechs dive deeper into targeted cancer research, despite costs
Biotechs dive deeper into targeted cancer research, despite costs
Biopharma Dive
biotech
clinical trials
cancer
drug development
Flag link:
Roche's Xofluza scores trial win in flu prevention, providing sales hope as Tamiflu craters
Roche's Xofluza scores trial win in flu prevention, providing sales hope as Tamiflu craters
Fierce Pharma
Roche
Xofluza
clinical trials
influenza
Flag link:
ASCO 2019 – The results of clinical practices changing phase III studies
ASCO 2019 – The results of clinical practices changing phase III studies
Pharmaforum
clinical trials
ASCO 2019
Merck
AstraZeneca
Flag link:
Gilead highlights Yescarta survival data in ASCO update
Gilead highlights Yescarta survival data in ASCO update
Pharmaforum
Gilead Sciences
clinical trials
Yescarta
relapsed or refractory diffuse large B-cell lymphoma
ASCO 2019
Flag link:
ASCO: Death in Turning Point NSCLC trial overshadows 82% ORR
ASCO: Death in Turning Point NSCLC trial overshadows 82% ORR
Fierce Biotech
ASCO 2019
clinical trials
Turning Point Therapeutics
repotrectinib
non-small cell lung cancer
Flag link:
ASCO: With FDA review nearing, Epizyme shares updated sarcoma data
ASCO: With FDA review nearing, Epizyme shares updated sarcoma data
Fierce Biotech
ASCO 2019
Epizyme
clinical trials
tazemetostat
epithelioid sarcoma
Flag link:
ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
ASCO: Novartis' Kisqali posts first-in-class survival win in younger women
Fierce Pharma
breast cancer
ASCO 2019
Novartis
clinical trials
Kisqali
Flag link:
Flipping the paradigm – how should biotechs harness adaptive trials?
Flipping the paradigm – how should biotechs harness adaptive trials?
Pharmaforum
clinical trials
adaptive trial design
Flag link:
Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment
Novartis burnishes prospects for its big asthma drug with positive PhIII data from a similar treatment
Endpoints
Novartis
asthma
QMF149
clinical trials
Flag link:
J&J passes key milestone in HIV vaccine trial
J&J passes key milestone in HIV vaccine trial
Pharmaforum
JNJ
Janssen
clinical trials
vaccines
HIV
Imbokodo
Flag link:
On the pulse of ASCO: pricing and clinical trial access
On the pulse of ASCO: pricing and clinical trial access
Pharmaforum
ASCO 2019
clinical trial access
clinical trials
oncology
drug pricing
Flag link:
Little Cara steers through their first positive PhIII with a ‘breakthrough’ drug and a path to the FDA
Little Cara steers through their first positive PhIII with a ‘breakthrough’ drug and a path to the FDA
Endpoints
Cara Therapeutics
Korsuva
CR845
clinical trials
hemodialysis
Flag link:
Newron delays pivotal schizophrenia trials amid safety fears
Newron delays pivotal schizophrenia trials amid safety fears
Fierce Biotech
Newron Pharma
clinical trials
FDA
schizophrenia
evenamide
Flag link:
Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials
Novartis’ inhaled asthma combo QVM149 succeeds in two phase 2 trials
Pharmaceutical Business Review
Novartis
QVM149
clinical trials
asthma
Flag link:
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
Biopharma Dive
uniQure
gene therapy
Huntington's disease
clinical trials
AMT-130
Flag link:
No news is bad news for Tocagen
No news is bad news for Tocagen
BioPharma Dive
Tocagen
Toca 511
Toca FC
brain cancer
clinical trials
Flag link:
Novartis' asthma triplet beats GSK's Advair in phase 2 trial
Novartis' asthma triplet beats GSK's Advair in phase 2 trial
Fierce Pharma
Novartis
asthma
QVM149
GSK
Advair
clinical trials
Flag link:

Pages